1 | follow-up | 56,310 |
2 | followup | 1,086 |
3 | follow-ups | 890 |
4 | post-loading | 34 |
5 | re-assessment | 30 |
6 | followups | 15 |
7 | five-years | 12 |
8 | teledentistry | 9 |
9 | defervesence | 7 |
10 | temporization | 7 |
11 | cost/patient | 6 |
12 | post-mri | 6 |
13 | look-back | 4 |
14 | rescan | 4 |
15 | study-1 | 4 |
16 | uti-free | 4 |
17 | 1992-2007 | 3 |
18 | 2012-2014 | 3 |
19 | 55.0°c | 3 |
20 | a=0.01 | 3 |
21 | baseline/screening | 3 |
22 | engagement-in-care | 3 |
23 | gh-therapy | 3 |
24 | jadad-score | 3 |
25 | lookback | 3 |
26 | nonmonsoon | 3 |
27 | pre-cis | 3 |
28 | time-horizon | 3 |
29 | 1400-1500 | 2 |
30 | 68-month | 2 |
31 | deglaciation | 2 |
32 | multiple-year | 2 |
33 | persistence/relapse | 2 |
34 | post-125i-tppb | 2 |
35 | post-placement | 2 |
36 | ppi-clarithromycin-rifabutin | 2 |
37 | pre-meld | 2 |
38 | resistogram | 2 |
39 | revocation | 2 |
40 | spinart | 2 |
41 | 'hibernation | 1 |
42 | 10-year-follow-up | 1 |
43 | 10.2-week | 1 |
44 | 10.9±1.4 | 1 |
45 | before-death | 1 |
46 | birthday-related | 1 |
47 | delay-start | 1 |
48 | difference=1.5 | 1 |
49 | disability.there | 1 |
50 | dssts | 1 |
51 | duration/arm | 1 |
52 | efs/pfs | 1 |
53 | facetime | 1 |
54 | folllow-up | 1 |
55 | follow-up-period | 1 |
56 | follow-up.allocation | 1 |
57 | follow-up.data | 1 |
58 | follow-up.how | 1 |
59 | follow-up.• | 1 |
60 | free-infection | 1 |
61 | hospitalization/ed | 1 |
62 | inter-survey | 1 |
63 | low-cholesterol-diet | 1 |
64 | lysimeter | 1 |
65 | mentstrual | 1 |
66 | mortality-rate | 1 |
67 | multi-therapies | 1 |
68 | non-trastuzumab | 1 |
69 | outcomes.all | 1 |
70 | pa*gender | 1 |
71 | post-angiogram | 1 |
72 | post-datscan | 1 |
73 | pre-employment/pre-placement | 1 |
74 | pre-intake | 1 |
75 | pre/post-observation | 1 |
76 | prenymphipositional | 1 |
77 | prerehabilitation | 1 |
78 | preven-tive | 1 |
79 | preworkload | 1 |
80 | protocol-32 | 1 |
81 | re-pvr | 1 |
82 | re-study | 1 |
83 | reinfection-free | 1 |
84 | relapse-risk | 1 |
85 | supplement-free | 1 |
86 | telephone-coaching | 1 |
87 | time-point*group | 1 |
88 | transplantation/mortality | 1 |
89 | trial.administration | 1 |
1 | 'hibernation | 1 |
2 | 10-year-follow-up | 1 |
3 | 10.2-week | 1 |
4 | 10.9±1.4 | 1 |
5 | 1400-1500 | 2 |
6 | 1992-2007 | 3 |
7 | 2012-2014 | 3 |
8 | 55.0°c | 3 |
9 | 68-month | 2 |
10 | a=0.01 | 3 |
11 | baseline/screening | 3 |
12 | before-death | 1 |
13 | birthday-related | 1 |
14 | cost/patient | 6 |
15 | defervesence | 7 |
16 | deglaciation | 2 |
17 | delay-start | 1 |
18 | difference=1.5 | 1 |
19 | disability.there | 1 |
20 | dssts | 1 |
21 | duration/arm | 1 |
22 | efs/pfs | 1 |
23 | engagement-in-care | 3 |
24 | facetime | 1 |
25 | five-years | 12 |
26 | folllow-up | 1 |
27 | follow-up | 56,310 |
28 | follow-up-period | 1 |
29 | follow-up.allocation | 1 |
30 | follow-up.data | 1 |
31 | follow-up.how | 1 |
32 | follow-up.• | 1 |
33 | follow-ups | 890 |
34 | followup | 1,086 |
35 | followups | 15 |
36 | free-infection | 1 |
37 | gh-therapy | 3 |
38 | hospitalization/ed | 1 |
39 | inter-survey | 1 |
40 | jadad-score | 3 |
41 | look-back | 4 |
42 | lookback | 3 |
43 | low-cholesterol-diet | 1 |
44 | lysimeter | 1 |
45 | mentstrual | 1 |
46 | mortality-rate | 1 |
47 | multi-therapies | 1 |
48 | multiple-year | 2 |
49 | non-trastuzumab | 1 |
50 | nonmonsoon | 3 |
51 | outcomes.all | 1 |
52 | pa*gender | 1 |
53 | persistence/relapse | 2 |
54 | post-125i-tppb | 2 |
55 | post-angiogram | 1 |
56 | post-datscan | 1 |
57 | post-loading | 34 |
58 | post-mri | 6 |
59 | post-placement | 2 |
60 | ppi-clarithromycin-rifabutin | 2 |
61 | pre-cis | 3 |
62 | pre-employment/pre-placement | 1 |
63 | pre-intake | 1 |
64 | pre-meld | 2 |
65 | pre/post-observation | 1 |
66 | prenymphipositional | 1 |
67 | prerehabilitation | 1 |
68 | preven-tive | 1 |
69 | preworkload | 1 |
70 | protocol-32 | 1 |
71 | re-assessment | 30 |
72 | re-pvr | 1 |
73 | re-study | 1 |
74 | reinfection-free | 1 |
75 | relapse-risk | 1 |
76 | rescan | 4 |
77 | resistogram | 2 |
78 | revocation | 2 |
79 | spinart | 2 |
80 | study-1 | 4 |
81 | supplement-free | 1 |
82 | teledentistry | 9 |
83 | telephone-coaching | 1 |
84 | temporization | 7 |
85 | time-horizon | 3 |
86 | time-point*group | 1 |
87 | transplantation/mortality | 1 |
88 | trial.administration | 1 |
89 | uti-free | 4 |
1 | 1400-1500 | 2 |
2 | study-1 | 4 |
3 | a=0.01 | 3 |
4 | protocol-32 | 1 |
5 | 10.9±1.4 | 1 |
6 | 2012-2014 | 3 |
7 | difference=1.5 | 1 |
8 | 1992-2007 | 3 |
9 | follow-up.data | 1 |
10 | non-trastuzumab | 1 |
11 | post-125i-tppb | 2 |
12 | 55.0°c | 3 |
13 | preworkload | 1 |
14 | hospitalization/ed | 1 |
15 | birthday-related | 1 |
16 | pre-meld | 2 |
17 | follow-up-period | 1 |
18 | defervesence | 7 |
19 | uti-free | 4 |
20 | reinfection-free | 1 |
21 | supplement-free | 1 |
22 | pre-intake | 1 |
23 | facetime | 1 |
24 | engagement-in-care | 3 |
25 | disability.there | 1 |
26 | jadad-score | 3 |
27 | persistence/relapse | 2 |
28 | mortality-rate | 1 |
29 | preven-tive | 1 |
30 | post-loading | 34 |
31 | telephone-coaching | 1 |
32 | baseline/screening | 3 |
33 | before-death | 1 |
34 | 68-month | 2 |
35 | post-mri | 6 |
36 | look-back | 4 |
37 | lookback | 3 |
38 | 10.2-week | 1 |
39 | relapse-risk | 1 |
40 | prenymphipositional | 1 |
41 | mentstrual | 1 |
42 | outcomes.all | 1 |
43 | post-angiogram | 1 |
44 | resistogram | 2 |
45 | duration/arm | 1 |
46 | rescan | 4 |
47 | post-datscan | 1 |
48 | ppi-clarithromycin-rifabutin | 2 |
49 | follow-up.allocation | 1 |
50 | revocation | 2 |
51 | deglaciation | 2 |
52 | 'hibernation | 1 |
53 | trial.administration | 1 |
54 | prerehabilitation | 1 |
55 | pre/post-observation | 1 |
56 | temporization | 7 |
57 | free-infection | 1 |
58 | nonmonsoon | 3 |
59 | time-horizon | 3 |
60 | folllow-up | 1 |
61 | follow-up | 56,310 |
62 | 10-year-follow-up | 1 |
63 | time-point*group | 1 |
64 | followup | 1,086 |
65 | multiple-year | 2 |
66 | pa*gender | 1 |
67 | lysimeter | 1 |
68 | re-pvr | 1 |
69 | multi-therapies | 1 |
70 | efs/pfs | 1 |
71 | pre-cis | 3 |
72 | follow-ups | 890 |
73 | followups | 15 |
74 | five-years | 12 |
75 | dssts | 1 |
76 | low-cholesterol-diet | 1 |
77 | cost/patient | 6 |
78 | pre-employment/pre-placement | 1 |
79 | post-placement | 2 |
80 | re-assessment | 30 |
81 | spinart | 2 |
82 | delay-start | 1 |
83 | follow-up.how | 1 |
84 | re-study | 1 |
85 | inter-survey | 1 |
86 | gh-therapy | 3 |
87 | teledentistry | 9 |
88 | transplantation/mortality | 1 |
89 | follow-up.• | 1 |